Atlas Trials

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Clinical trial NCT00787969 · COMPLETED

Trial details

NCT number
NCT00787969
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lymphoma
Start date
2009-04-01
Primary completion
2012-04-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.